Replies to post #2714 on Biostax Corp (BTAX)

[SF Wolf]

This is the news we have all been waiting for. Highlights from the press release below outline the importance of NAFDAC approval. Marketing agreements likely to follow.

"National Agency for Food and Drug Administration and Control (“NAFDAC”) approval paves way for Immune Therapeutics’ first significant revenue channel

Immune Therapeutics’ goal to capture 20% share of Nigeria’s billion-dollar HIV/AIDS treatment market

Lodonal to represent a significant “breakthrough” as the first affordable, non-toxic adjunct therapy for HIV/AIDS
Company expected to strengthen management team to spearhead commercialization throughout Africa

With initial contracts expected shortly, company on-track to meet guidance of achieving profitability by end of current fiscal year"